Cecilia Larocca

1.5k total citations · 1 hit paper
37 papers, 1.0k citations indexed

About

Cecilia Larocca is a scholar working on Dermatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Cecilia Larocca has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Dermatology, 16 papers in Pathology and Forensic Medicine and 12 papers in Immunology. Recurrent topics in Cecilia Larocca's work include Cutaneous lymphoproliferative disorders research (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and T-cell and Retrovirus Studies (7 papers). Cecilia Larocca is often cited by papers focused on Cutaneous lymphoproliferative disorders research (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and T-cell and Retrovirus Studies (7 papers). Cecilia Larocca collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Cecilia Larocca's co-authors include Jeffrey Schlom, Thomas S. Kupper, Erin M. Bowers, Philip A. Cole, David J. Meyers, Gai Yan, Rhoda M. Alani, S. Adrian Saldanha, Yan Sun and Ronen Marmorstein and has published in prestigious journals such as Blood, Neurology and Clinical Cancer Research.

In The Last Decade

Cecilia Larocca

27 papers receiving 1.0k citations

Hit Papers

Virtual Ligand Screening of the p300/CBP Histone Acetyltr... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilia Larocca United States 12 610 303 253 133 113 37 1.0k
Kavitha Gowrishankar Australia 19 770 1.3× 636 2.1× 331 1.3× 41 0.3× 147 1.3× 34 1.3k
Paula Aguilera Spain 22 549 0.9× 570 1.9× 161 0.6× 338 2.5× 202 1.8× 84 1.3k
Elizabeth K. Duperret United States 18 474 0.8× 435 1.4× 476 1.9× 56 0.4× 52 0.5× 25 1.1k
Gilbert Scott United States 7 574 0.9× 360 1.2× 247 1.0× 45 0.3× 33 0.3× 9 919
Maxim A. X. Tollenaere Denmark 13 760 1.2× 157 0.5× 109 0.4× 55 0.4× 38 0.3× 16 965
Gwenola Bougras France 14 477 0.8× 355 1.2× 873 3.5× 37 0.3× 119 1.1× 18 1.4k
David Klinkebiel United States 18 691 1.1× 258 0.9× 320 1.3× 28 0.2× 61 0.5× 35 1.1k
Jens Peter H. Lauritsen Denmark 19 391 0.6× 277 0.9× 935 3.7× 69 0.5× 60 0.5× 33 1.3k
David W. LaFleur United States 17 402 0.7× 355 1.2× 531 2.1× 25 0.2× 129 1.1× 22 1.2k
Yulius Y. Setiady United States 18 427 0.7× 293 1.0× 428 1.7× 36 0.3× 42 0.4× 35 1.1k

Countries citing papers authored by Cecilia Larocca

Since Specialization
Citations

This map shows the geographic impact of Cecilia Larocca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Larocca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Larocca more than expected).

Fields of papers citing papers by Cecilia Larocca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Larocca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Larocca. The network helps show where Cecilia Larocca may publish in the future.

Co-authorship network of co-authors of Cecilia Larocca

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Larocca. A scholar is included among the top collaborators of Cecilia Larocca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Larocca. Cecilia Larocca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, David C., et al.. (2024). Case Report: Mogamulizumab-associated Myositis (P11-11.014). Neurology. 102(17_supplement_1).
2.
Kim, Emily, et al.. (2023). Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema. Acta Dermato Venereologica. 103. adv12197–adv12197.
3.
Khan, Niloufer, Esther Drill, Alison J. Moskowitz, et al.. (2023). Quality of Life and Global Response Score in Cutaneous T-Cell Lymphoma. Blood. 142(Supplement 1). 381–381.
4.
Jfri, Abdulhadi, César A. Virgen, Marianne Tawa, et al.. (2023). Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience. Journal of the American Academy of Dermatology. 89(5). 1044–1047. 3 indexed citations
5.
Virgen, César A., Jeffrey A. Sparks, Anju Nohria, et al.. (2023). Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma. The Oncologist. 28(8). e694–e698. 3 indexed citations
6.
Jfri, Abdulhadi, et al.. (2023). Clinical Features and Management of Dermatologic Immune-Related Adverse Events for the Inpatient Dermatologist. Current Dermatology Reports. 12(3). 136–146. 1 indexed citations
7.
McLellan, Beth N., et al.. (2023). Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies. American Journal of Clinical Dermatology. 24(5). 765–785. 1 indexed citations
8.
Gupta, Neha, César A. Virgen, Amrita Goyal, et al.. (2023). Novel use of acitretin for posttransplant Grover’s disease and cutaneous graft versus host disease. JAAD Case Reports. 33. 67–69.
9.
LeBoeuf, Nicole R., et al.. (2023). Harnessing the immune system in the treatment of cutaneous T cell lymphomas. Frontiers in Oncology. 12. 1071171–1071171. 2 indexed citations
10.
Smith, Neal P., Jessica E. Teague, Pablo Vieyra-Garcia, et al.. (2022). IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma. Journal of Investigative Dermatology. 142(8). 2285–2288.e2. 4 indexed citations
11.
Jfri, Abdulhadi, Jeffrey S. Smith, & Cecilia Larocca. (2022). Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review. Journal of the American Academy of Dermatology. 88(5). 1164–1166. 13 indexed citations
12.
Bui, Ai‐Tram N., Cecilia Larocca, Anita Giobbie‐Hurder, Eric D. Jacobsen, & Nicole R. LeBoeuf. (2021). Cutaneous Langerhans cell histiocytosis in adults: A retrospective cohort study of adult patients presenting to a single academic cancer center between 2003 and 2017. Journal of the American Academy of Dermatology. 86(6). 1413–1416. 1 indexed citations
13.
Larocca, Cecilia, Nicole R. LeBoeuf, Ann W. Silk, & Howard L. Kaufman. (2020). An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions. American Journal of Clinical Dermatology. 21(6). 821–832. 32 indexed citations
14.
Bui, Ai‐Tram N., Sean Singer, Amy Cunningham‐Bussel, et al.. (2020). De novo cutaneous connective tissue disease temporally associated with immune checkpoint inhibitor therapy: A retrospective analysis. Journal of the American Academy of Dermatology. 84(3). 864–869. 17 indexed citations
15.
O’Malley, John T., Adèle de Masson, Elizabeth L. Lowry, et al.. (2019). Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clinical Cancer Research. 26(2). 408–418. 17 indexed citations
16.
Larocca, Cecilia & Nicole R. LeBoeuf. (2019). Overview of Cutaneous T-Cell Lymphomas. Hematology/Oncology Clinics of North America. 33(4). 669–686. 12 indexed citations
17.
Larocca, Cecilia & Thomas S. Kupper. (2018). Mycosis Fungoides and Sézary Syndrome. Hematology/Oncology Clinics of North America. 33(1). 103–120. 67 indexed citations
18.
Larocca, Cecilia, et al.. (2013). An Autocrine Loop between TGF-β1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype. Molecular Cancer Therapeutics. 12(9). 1805–1815. 53 indexed citations
19.
Bowers, Erin M., Gai Yan, Chandrani Mukherjee, et al.. (2010). Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor. Chemistry & Biology. 17(5). 471–482. 504 indexed citations breakdown →
20.
Larocca, Cecilia, et al.. (1998). Adaptive hepatic changes in mild stenosis of the common bile duct in the rat. Research in Experimental Medicine. 198(6). 307–323. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026